Business Context and Reporting Period
This Form 8-K was filed by MRI Interventions, Inc. on April 27, 2017. The filing reports the financial performance for the first fiscal quarter ended March 31, 2017. The registrant is incorporated in Delaware and maintains its principal executive offices in Irvine, California.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a notification that a press release containing these details (Exhibit 99.1) has been issued, but the financial data itself is not embedded in the body of this 8-K report.
Material Changes
No material changes or comparative financial data versus prior periods are detailed in the text of this filing. The report references an attached press release for the specific results of operations.
Guidance, Outlook, and Risks
The filing does not contain management commentary, forward-looking guidance, risk factors, or contingencies. It explicitly states that the information in Item 2.02 and the attached press release shall not be deemed "filed" for purposes of Section 18 of the Exchange Act nor incorporated by reference into other filings, except as expressly set forth by specific reference.
Investor Verification Checklist
- Verify the specific financial results (revenue, net loss, cash position) by reviewing the attached Exhibit 99.1 (Press Release dated April 27, 2017), as these figures are absent from the 8-K text.
- Confirm the company name discrepancy: The request metadata lists "Clearpoint Neuro, Inc.," but the filing is for MRI Interventions, Inc.
- Note that the financial data in this filing is not legally "filed" under Section 18 of the Exchange Act, limiting liability protections for the data presented in the press release.